We are taking a hard look at Tirzepatide, the GLP-1/GIP drug making waves far beyond weight loss, and asking whether the hype matches the science. From its promising non-weight-loss health benefits to the bold claim that most adults should consider it, we are breaking down where the research is strong, where it is still limited, and why broad recommendations can be risky.
We are also talking about accountability in the fitness industry, why it is often missing, and what it takes to raise the standard for both coaches and clients. Along the way we touch on Hulk Hoganās controversies and what they say about responsibility in sport.
And if you have not already, grab our free Fantastic Four and Superman inspired training programs by hitting the Linktree and checking out our latest posts on Instagram.
Tap the Linktree to catch the episode and explore more from the world of Reps and References.
š Linktree: ā https://linktr.ee/repsandreferencesā
